{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:38:37Z","timestamp":1794332317869,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.expneurol.2026.116044","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:35:59Z","timestamp":1790868959000},"page":"116044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fluid amyloid-\u03b2 (A\u03b2) biomarkers reflect early \u03b2-sheet-rich A\u03b2 deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice"],"prefix":"10.1016","volume":"408","author":[{"given":"Hiroko","family":"Yagihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko N.","family":"Minakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.116044_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13195-023-01196-8","article-title":"Cerebral A\u03b2 deposition precedes reduced cerebrospinal fluid and serum A\u03b242\/A\u03b240 ratios in the AppNL\u2212F\/NL\u2212F knock-in mouse model of Alzheimer\u2019s disease","volume":"15","author":"Andersson","year":"2023","journal-title":"Alz. Res. Therapy"},{"key":"10.1016\/j.expneurol.2026.116044_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s43587-025-00810-8","article-title":"Soluble cerebral A\u03b2 protofibrils link A\u03b2 plaque pathology to changes in CSF A\u03b242\/A\u03b240 ratios, neurofilament light and tau in Alzheimer\u2019s disease model mice","volume":"5","author":"Andersson","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.expneurol.2026.116044_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110161","article-title":"Tau transgenic mice as models for cerebrospinal fluid Tau biomarkers","volume":"24","author":"Barten","year":"2011","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.expneurol.2026.116044_bb0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(23)00274-0","article-title":"Preparing for disease-modifying therapies in Alzheimer\u2019s disease","volume":"22","author":"Belder","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2026.116044_bb0025","first-page":"986310","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid","volume":"2010","author":"Bjerke","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2026.116044_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-022-02458-9","article-title":"Blood-based A\u03b242 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention","volume":"144","author":"Botella Lucena","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.116044_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp-2021-327864","article-title":"Plasma A\u03b2 as a biomarker for predicting A\u03b2-PET status in Alzheimer\u2019s disease: a systematic review with meta-analysis","volume":"93","author":"Cheng","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2026.116044_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70580","article-title":"Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation","volume":"21","author":"Danhash","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2026.116044_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116044_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.116044_bb0055","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","article-title":"New landscape of the diagnosis of Alzheimer\u2019s disease","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2026.116044_bb0060","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1038\/s41598-020-67284-z","article-title":"Hybrid PET\/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer\u2019s disease mouse model","volume":"10","author":"Frost","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.116044_bb0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1101\/gr.233866.117","article-title":"Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis","volume":"29","author":"Goodwin","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.expneurol.2026.116044_bb0070","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid \u03b2 protein (A\u03b2) in Alzheimeri\u2019s disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.116044_bb0075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2026.116044_bb0080","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2026.116044_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alz. Res. Therapy"},{"key":"10.1016\/j.expneurol.2026.116044_bb0090","first-page":"40","article-title":"Generation of sophisticated Alzheimer\u2019s disease mouse models and research advances utilizing them","volume":"5","author":"Hashimoto","year":"2023","journal-title":"Transl. Reg. Sci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0095","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer\u2019s disease\u2014opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2026.116044_bb0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.116044_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific a\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.116044_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2014.01.003","article-title":"Changes in the brain and plasma a\u03b2 peptide levels with age and its relationship with cognitive impairment in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"263","author":"Izco","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2026.116044_bb0115","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2026.116044_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116044_bb0125","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2026.116044_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.785276","article-title":"Systematic phenotyping and characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"15","author":"Javonillo","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0135","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227618","article-title":"Alterations of aqueous humor A\u03b2 levels in A\u03b2-infused and transgenic mouse models of Alzheimer disease","volume":"15","author":"Kwak","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.116044_bb0145","doi-asserted-by":"crossref","DOI":"10.3791\/960","article-title":"A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse","author":"Liu","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2026.116044_bb0150","doi-asserted-by":"crossref","first-page":"194re2","DOI":"10.1126\/scitranslmed.3006446","article-title":"Changes in amyloid-\u03b2 and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein","volume":"5","author":"Maia","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.116044_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.expneurol.2026.116044_bb0160","doi-asserted-by":"crossref","first-page":"e1137","DOI":"10.1212\/WNL.0000000000200040","article-title":"Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration","volume":"98","author":"Mattsson-Carlgren","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2026.116044_bb0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neulet.2017.05.054","article-title":"Chronic sleep fragmentation exacerbates amyloid \u03b2 deposition in Alzheimer\u2019s disease model mice","volume":"653","author":"Minakawa","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2026.116044_bb0170","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","article-title":"Temporal memory deficits in Alzheimer\u2019s mouse models: rescue by genetic deletion of BACE1","volume":"23","author":"Ohno","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.114970","article-title":"Age-related changes in species-typical behaviours in the 5xFAD mouse model of Alzheimer\u2019s disease from 4 to 16 months of age","volume":"465","author":"O\u2019Leary","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2026.116044_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00412-5","article-title":"A novel systems biology approach to evaluate mouse models of late-onset Alzheimer\u2019s disease","volume":"15","author":"Preuss","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116044_bb0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","article-title":"Detection and treatment of Alzheimer\u2019s disease in its preclinical stage","volume":"3","author":"Rafii","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.expneurol.2026.116044_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-10-1","article-title":"A\u03b2 reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level","volume":"10","author":"Sadleir","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116044_bb0205","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0210","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217123","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads","volume":"15","author":"Salvad\u00f3","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116044_bb0215","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2026.116044_bb0220","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF a\u03b2 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2026.116044_bb0225","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","article-title":"Staging of Alzheimer\u2019s disease: past, present, and future perspectives","volume":"28","author":"Therriault","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116044_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14442","article-title":"Plasma A\u03b242\/A\u03b240 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer\u2019s disease spectrum","volume":"21","author":"Trelle","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2026.116044_bb0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41467-019-13962-0","article-title":"FAM222A encodes a protein which accumulates in plaques in Alzheimer\u2019s disease","volume":"11","author":"Yan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.116044_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.912995","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"15","author":"Yokoyama","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116044_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer\u2019s disease","volume":"19","author":"Zhong","year":"2024","journal-title":"Mol. Neurodegener."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:02:18Z","timestamp":1794330138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626004115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":49,"alternative-id":["S0014488626004115"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116044","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid amyloid-\u03b2 (A\u03b2) biomarkers reflect early \u03b2-sheet-rich A\u03b2 deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116044"}}